El-Osta H - Search Results

1

Acute Promyelocytic Leukemia and Chronic Lymphocytic Leukemia: Concomitant Presentation of Two Molecularly Distinct Entities.

Su J, Veillon D, Shackelford R, Cotelingam J, El-Osta H, Mills G, Munker R, Devarakonda S. Su J, et al. Among authors: el osta h. J La State Med Soc. 2017 May-Jun;169(3):68-70. Epub 2017 Jun 23. J La State Med Soc. 2017. PMID: 28644154 Review.

2

Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.

Ansari J, Naqash AR, Munker R, El-Osta H, Master S, Cotelingam JD, Griffiths E, Greer AH, Yin H, Peddi P, Shackelford RE. Ansari J, et al. Eur J Haematol. 2016 Jul;97(1):9-16. doi: 10.1111/ejh.12755. Epub 2016 Apr 8. Eur J Haematol. 2016. PMID: 26990812 Review.

3

Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib.

El-Osta H, Shackelford R. El-Osta H, et al. Pharmgenomics Pers Med. 2015 Sep 29;8:145-54. doi: 10.2147/PGPM.S71100. eCollection 2015. Pharmgenomics Pers Med. 2015. PMID: 26622190 Free PMC article. Review.

4

Epigenetics in non-small cell lung cancer: from basics to therapeutics.

Ansari J, Shackelford RE, El-Osta H. Ansari J, et al. Transl Lung Cancer Res. 2016 Apr;5(2):155-71. doi: 10.21037/tlcr.2016.02.02. Transl Lung Cancer Res. 2016. PMID: 27186511 Free PMC article. Review.

5

Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment.

El-Osta H, Shahid K, Mills GM, Peddi P. El-Osta H, et al. Onco Targets Ther. 2016 Aug 16;9:5101-16. doi: 10.2147/OTT.S111209. eCollection 2016. Onco Targets Ther. 2016. PMID: 27574451 Free PMC article. Review.

6

Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.

Circu M, Cardelli J, Barr MP, O'Byrne K, Mills G, El-Osta H. Circu M, et al. Among authors: el osta h. PLoS One. 2017 Sep 25;12(9):e0184922. doi: 10.1371/journal.pone.0184922. eCollection 2017. PLoS One. 2017. PMID: 28945807 Free PMC article.

7

Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.

Circu M, Cardelli J, Barr MP, O'Byrne K, Mills G, El-Osta H. Circu M, et al. Among authors: el osta h. PLoS One. 2018 May 2;13(5):e0197016. doi: 10.1371/journal.pone.0197016. eCollection 2018. PLoS One. 2018. PMID: 29718985 Free PMC article.

8

Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam.

Peddi P, Ajit NE, Burton GV, El-Osta H. Peddi P, et al. BMJ Case Rep. 2016 Dec 23;2016:bcr2016217393. doi: 10.1136/bcr-2016-217393. BMJ Case Rep. 2016. PMID: 28011886 Free PMC article.

9

Rituximab-induced acute thrombocytopenia: an underappreciated entity.

El-Osta H, Nair B. El-Osta H, et al. Leuk Lymphoma. 2013 Dec;54(12):2736-7. doi: 10.3109/10428194.2013.784972. Epub 2013 Apr 22. Leuk Lymphoma. 2013. PMID: 23488605 No abstract available.

10

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight.

Peddi P, Paryani B, Takalkar A, Bundrick P, Ponugupati J, Nair B, El-Osta H. Peddi P, et al. Onco Targets Ther. 2016 Feb 9;9:705-9. doi: 10.2147/OTT.S99667. eCollection 2016. Onco Targets Ther. 2016. PMID: 26929641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters